Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats

Batista, KNI; Schraner, M; Riediger, T

Riediger, T (corresponding author), Univ Zurich, Inst Vet Physiol, Zurich, Switzerland.

NEUROPHARMACOLOGY, 2020; 180 ():

Abstract

Up to 80% of cancer patients are affected by the cancer anorexia-cachexia syndrome (CACS), which leads to excessive body weight loss, reduced treatmen......

Full Text Link